adequate dosage according to various developmental stages ( neonate , infant , child , adolescent ) , specific pediatric forms issued from clinical and pharmacokinetics trials in children , galenic drugs suitable for pediatric use without side effects especially for topical preparations , remodelling of adult forms into pediatric forms without loss of effectiveness are some of the main problems .
C0021270
infant
C0008059
children